Clinical Trial Update: N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial tested N-acetylcysteine to reduce oxidative stress and improve endothelial function in older adults with HIV. Trial results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• HIV Infection

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Indiana University | Conditions: HIV, Endothelial Dysfunction | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-02-08